Search research articles
Contact Us
Filters
Showing results (241-250 of 286) with videos related to
Page
of 29
Sort By:
Nature Medicine
|
February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, et al.
Data in Brief
|
April 14, 2021
ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma
Pejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Scientific Reports
|
December 2, 2020
Novel tonometer device distinguishes brain stiffness in epilepsy surgery
Aria Fallah, Thirusivapragasam Subramaniam, H Westley Phillips, et al.
Neuroimage. Clinical
|
December 16, 2021
"Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging
Akifumi Hagiwara, Jingwen Yao, Catalina Raymond, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2021
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
Pejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Neuro-Oncology
|
February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Timothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced Glioma
Ingo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
Neuro-Oncology
|
January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial
John H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Journal of Neuro-Oncology
|
June 9, 2023
Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas
Nicholas S Cho, Francesco Sanvito, Shruti Thakuria, et al.
Frontiers in Oncology
|
April 4, 2022
Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease
Jodi Goldman, Akifumi Hagiwara, Jingwen Yao, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 286) with videos related to
Sort By:
Page
of 29
Nature Medicine
|
February 24, 2023
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, et al.
Data in Brief
|
April 14, 2021
ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma
Pejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Scientific Reports
|
December 2, 2020
Novel tonometer device distinguishes brain stiffness in epilepsy surgery
Aria Fallah, Thirusivapragasam Subramaniam, H Westley Phillips, et al.
Neuroimage. Clinical
|
December 16, 2021
"Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging
Akifumi Hagiwara, Jingwen Yao, Catalina Raymond, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 8, 2021
Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma
Pejman Jabehdar Maralani, Sten Myrehaug, Hatef Mehrabian, et al.
Neuro-Oncology
|
February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
Timothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 13, 2020
Ivosidenib in Isocitrate Dehydrogenase 1<i>-</i>Mutated Advanced Glioma
Ingo K Mellinghoff, Benjamin M Ellingson, Mehdi Touat, et al.
Neuro-Oncology
|
January 14, 2023
Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial
John H Sampson, Achal Singh Achrol, Manish K Aghi, et al.
Journal of Neuro-Oncology
|
June 9, 2023
Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas
Nicholas S Cho, Francesco Sanvito, Shruti Thakuria, et al.
Frontiers in Oncology
|
April 4, 2022
Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease
Jodi Goldman, Akifumi Hagiwara, Jingwen Yao, et al.
Page
of 29